Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.170
+0.060 (1.93%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Niagen Bioscience Market Cap
Niagen Bioscience has a market cap or net worth of $251.36 million as of September 4, 2026. Its market cap has decreased by -67.41% in one year.
Market Cap
251.36M
Enterprise Value
187.10M
1-Year Change
-67.41%
Ranking
Category
Stock Price
$3.17
ChartMarket Cap Chart
Since June 25, 2008, Niagen Bioscience's market cap has decreased from $909.70M to $251.36M, a decrease of -72.37%. That is a compound annual growth rate of -6.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 250.80M | -50.59% |
| Dec 31, 2025 | 507.60M | 25.27% |
| Dec 31, 2024 | 405.20M | 277.28% |
| Dec 29, 2023 | 107.40M | -14.15% |
| Dec 30, 2022 | 125.10M | -51.02% |
| Dec 31, 2021 | 255.40M | -13.89% |
| Dec 31, 2020 | 296.60M | 15.50% |
| Dec 31, 2019 | 256.80M | 35.87% |
| Dec 31, 2018 | 189.00M | -33.29% |
| Dec 29, 2017 | 283.30M | 125.74% |
| Dec 30, 2016 | 125.50M | -5.71% |
| Dec 31, 2015 | 133.10M | 41.45% |
| Dec 31, 2014 | 94.10M | -40.97% |
| Dec 31, 2013 | 159.40M | 224.64% |
| Dec 31, 2012 | 49.10M | 19.76% |
| Dec 30, 2011 | 41.00M | -49.88% |
| Dec 31, 2010 | 81.80M | 544.09% |
| Dec 31, 2009 | 12.70M | -95.35% |
| Dec 31, 2008 | 272.90M | -70.00% |
| Jun 25, 2008 | 909.70M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 258.53M |
| YD Bio | 258.07M |
| Neumora Therapeutics | 253.66M |
| Atrium Therapeutics | 249.74M |
| NervGen Pharma | 249.45M |
| Cellectis | 249.09M |
| Adagene | 247.76M |
| Invivyd | 246.12M |